LIM domain-containing protein Trip6 can act as a coactivator for the v- Rel transcription factor

Gene Expression

Volumn 8, Issue 4, 1999, Pages 207-217

  Zhao, Marieke Koedood ^a,c   Wang, Yuan ^a   Murphy, Kerry ^a,d   Yi, Jinseong ^b   Beckerle, Mary C ^b   Gilmore, Thomas D ^a  

^a USA   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c PFIZER INC   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

LIM domain; Malignant transformation; NF B; Retroviral oncogene; Transcription factor; Trip6 Coactivator; Two hybrid assay; v Rel

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION; GENE LOCATION; NONHUMAN; PROTEIN DNA BINDING; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; GENES, REL; HOMEODOMAIN PROTEINS; HUMANS; ORGAN SPECIFICITY; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EUKARYOTA; GALLUS GALLUS;

EID: 0033508355     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Beckerle, M. C. Zyxin: Zinc fingers at sites of cell adhesion. Bioessays 19:949-957; 1997.
2. Bohen, S. P.; Yamamoto, K. R. Isolation of Hsp90 mutants by screening for decreased receptor function. Proc. Natl. Acad. Sci. USA 90:11424-11428; 1993.
3. Bray, S. A notch affair. Cell 93:499-503; 1998.
4. Brown, M. S.; Goldstein, J. L. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89:331-340; 1997.
5. Chen, C.; Agnès, F.; Gèlinas, C. Mapping of a serinerich domain essential for the transcriptional, antiapoptotic, and transforming activities of the v-Rel oncoprotein. Mol. Cell. Biol. 19:307-316; 1999.
6. Claret, F.-X.; Hibi, M.; Dhut, S.; Toda, T.; Karin, M. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383:453-457; 1996.
7. Cuppen, E.; Wieringa, B.; Hendricks, W. GenBank Accession AF097511; 1998.
8. Darnell, J. E., Jr. STATs and gene regulation. Science 277:1630-1635; 1997.
9. Dawid, I. B.; Breen, J. J.; Toyama, R. LIM domains: Multiple roles as adaptors and functional modifiers in protein interactions. Trends Genet. 14:156-162; 1998.
10. Dechend, R.; Hirano, F.; Lehmann, K.; Heissmeyer, V.; Ansieau, S.; Wulczyn, F. G.; Scheidereit, C.; Leutz, A. The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators. Oncogene 18:3316-3323; 1999.
11. Durfee, T.; Becherer, K.; Chen, P. -L.; Yeh, S. -H.; Yang, Y.; Kilburn, A. E.; Lee, W. -H.; Elledge, S. J. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev. 7:555-569; 1993.
12. Fimia, G. M.; De Cesare, D.; Sassone-Corsi, P. CBP-independent activation of CREM and CREB by the LIM-only protein ACT. Nature 398:165-169; 1999.
13. Gelinas, C.; Temin, H. M. The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters. Oncogene 3:349-355; 1988.
14. Gilmore, T. D. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel. Oncogene 18:6925-6937; 1999.
15. Gilmore, T. D.; Temin H. M. Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by REV-T. Cell 44:791-800; 1986.
16. Gilmore, T. D.; White, D. W.; Sarkar, S.; Sif, S. Malignant transformation of cells by the v-Rel oncoprotein. In: Cooper, G. M.; Greenberg Temin, R.; Sugden, B., eds. The DNA provirus: Howard Temin's scientific legacy. Washington DC: American Society for Microbiology; 1995:105-124.
17. Guarente, L. Transcriptional coactivators in yeast and beyond. Trends Biochem. Sci. 20:517-521; 1995.
18. Hatzivassiliou, E.; Cardot, P.; Zannis, V. I.; Mitsialis, S. A. Ultrasipiracle, a Drosophila retinoic X receptor alpha homologue, can mobilize the human thyroid hormone receptor to transactivate a human promoter. Biochemistry 36:9221-9231; 1997.
19. Ishikawa, H.; Asano, M.; Kanda, T.; Kumar, S.; Gélinas, C.; Ito, Y. Two novel functions associated with the Rel oncoproteins: DNA replication and cell-specific transcriptional activation. Oncogene 8:2889-2896; 1993.
20. Kamens, J.; Brent, R. A yeast transcription assay defines distinct Rel and Dorsal DNA recognition sequences. New Biol. 3:1005-1013; 1991.
21. Kamens, J.; Richardson, P.; Mosialos, G.; Brent, R.; Gilmore, T. Oncogenic transformation by vRel requires an amino-terminal activation domain. Mol. Cell. Biol. 10:2840-2847; 1990.
22. Kerr, L. D.; Ransone, L. J.; Wamsley, P.; Schmitt, M. J.; Boyer, T. G.; Zhou, Q.; Berk, A. J.; Verma, I. M. Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-κB. Nature 365:412-419; 1993.
23. Lee, J. W.; Choi, H. -S.; Gyuris, J.; Brent, R.; Moore, D. D. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol. Endocrinol. 9:243-254; 1995.
24. Murthy, K. K.; Clark, K.; Fortin, Y.; Shen, S. -H.; Banville, D. ZRP-2, a zyxin-related protein, interacts with the second PDZ domain of the cytosolic protein tyrosine phosphatase hPTP1E. J. Biol. Chem. 274:20679-20687; 1999.
25. Nix, D. A.; Beckerle, M. C. Nuclear-cytoplasmic shuttling of the focal contact protein, zyxin: A potential mechanism for communication between sites of cell adhesion and the nucleus. J. Cell Biol. 138:1139-1147; 1997.
26. Richardson, P. M.; Gilmore, T.D. v-Rel is an inactive member of the Rel family of transcriptional activating proteins. J. Virol. 65:3122-3130; 1991.
27. Sadowski, I.; Ptashne, M. Vector for expressing GAL4(1-147) fusions in mammalian cells. Nucleic Acids Res. 17:7539; 1989.
28. Sarkar, S.; Gilmore, T. D. Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel Homology domain. Oncogene 8:2245-2252; 1993.
29. Smardova, J.; Walker, A.; Morrison, L. E.; Kabrun, N.; Enrietto, P. The role of the carboxy terminus of v-Rel in transformation and activation of endogenous gene expression. Oncogene 10:113-119; 1995.
30. Wang, Y.; Dooher, J. E.; Koedood Zhao, M.; Gilmore, T. D. Characterization of mouse Trip6: A putative intracellular signaling protein. Gene 234:403-409; 1999.
31. White, D. W.; Gilmore, T. D. Temperature-sensitive transforming mutants of the v-rel oncogene. J. Virol. 67:6876-6881; 1993.
32. White, D. W.; Pitoc, G. A.; Gilmore, T. D. Interaction of the v-Rel oncoprotein with NF-κB and IκB proteins: Heterodimers of a transformation-defective v-Rel mutant and NF-κB p52 are functional in vitro and in vivo. Mol. Cell. Biol. 16:1169-1178; 1996.
33. Williams, J. M.; Chen, G. C.; Shu, L.; Rest, R. F. Using the yeast two-hybrid system to identify human epithelial cell proteins that bind bonococcal Opa proteins: Intracellular gonococci bind pyruvate kinase via their Opa proteins and require host pyruvate for growth. Mol. Microbiol. 27:171-186; 1998.
34. Xu, X.; Prorock, C.; Ishikawa, H.; Maldonado, E.; Ito, Y.; Galinas, C. Functional interaction of the v-Rel and c-Rel oncoproteins with the TATA-binding protein and association with transcription factor IIB. Mol. Cell. Biol. 13:6733-6741; 1993.
35. Yi, J.; Beckerle, M. C. The human TRIP6 gene encodes a LIM domain protein and maps to chromosome 7q22, a region associated with tumorigenesis. Genomics 49:314-316; 1998.